Press Releases

• Active Biotech’s patent related to a pharmaceutical formulation of tasquinimod will be granted in the US
  Nov 25, 2025 10:00 (CET)
• The subscription period in Active Biotech’s rights issue begins today
  Nov 25, 2025 08:30 (CET) Regulatory
• Positive preclinical tasquinimod data in myelofibrosis published in Blood Advances
  Nov 24, 2025 09:30 (CET)
• Active Biotech publishes information document regarding rights issue
  Nov 20, 2025 15:45 (CET) Regulatory
• Extraordinary General Meeting of Active Biotech AB
  Nov 19, 2025 12:00 (CET) Regulatory